Spengler, Jessica R. Welch, Stephen R. Deval, Jerome  Gentry,  Brian G.Brancale,  Andrea Carter, Kara Moffat, Jennifer Meier, Chris Seley-Radtke, KatherineSchang, Luis M. 2023-04-122023-04-122023-01-12Spengler, Jessica R. et al. "Meeting report: 35th International Conference on Antiviral Research in Seattle, Washington, USA – March 21–25, 2022." Antiviral Research 211(12 January 2023). https://doi.org/10.1016/j.antiviral.2022.105521https://doi.org/10.1016/j.antiviral.2022.105521http://hdl.handle.net/11603/27599The 35th International Conference on Antiviral Research (ICAR), sponsored by the International Society for Antiviral Research (ISAR), was held in Seattle, Washington, USA, on March 21–25, 2022 and concurrently through an interactive remote meeting platform. This report gives an overview of the conference on behalf of the society. It provides a general review of the meeting and awardees, summarizing the presentations and their main conclusions from the perspective of researchers active in many different areas of antiviral research and development. Through ICAR, leaders in the field of antiviral research were able to showcase their efforts, as participants learned about key advances in the field. The impact of these efforts was exemplified by many presentations on SARS-CoV-2 demonstrating the remarkable response to the ongoing pandemic, as well as future pandemic preparedness, by members of the antiviral research community. As we address ongoing outbreaks and seek to mitigate those in the future, this meeting continues to support outstanding opportunities for the exchange of knowledge and expertise while fostering cross-disciplinary collaborations in therapeutic and vaccine development. The 36th ICAR will be held in Lyon, France, March 13–17, 2023.20 pagesen-USThis work was written as part of one of the author's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.Public Domain Mark 1.0http://creativecommons.org/publicdomain/mark/1.0/Text